Patient finding

The patients most pharma data tools can't find

Ada reaches patients before they enter the healthcare system before any claim, any specialist visit or any ICD-10 code. A population exclusive to Ada.

The patients you're missing aren't in your data yet

Claims data, EMR mining, and point-of-care tools all require the patient to have already entered the healthcare system. Ada doesn’t. Here’s how it works:

1. Patient describes symptoms to Ada

2. Ada’s clinical AI identifies a probable condition

3. Unique user journey data insight delivered to partner

Exclusive clinical insights

Patient insights for your target health condition appear in the clinical reasoning output of Ada’s CE-marked Class IIa medical device (EU MDR 2017/745). These are patients with no claims trail, no prior specialist visit and no EMR record. They are invisible to most common patient identification tools used by pharma.

Clinical evidence

50+ peer-reviewed publications

The earlier Ada gets to them, the faster they get to care

30,500

health conditions covered

Ada Health

64.4%

of patients make clinically appropriate care decisions after an Ada assessment

Cotte et al., NEJM AI, 2026

59.1%

of patients changed their care pathway after an Ada assessment

Cotte et al., NEJM AI, 2026

Ada’s assessment covers 30,500 ICD-10 codes across 12 languages and 150 countries. Clinical evidence spans 50+ peer-reviewed publications with research partners including Brown University, Charité, Stanford, the NHS, and the WHO.

50+

peer-reviewed publications

97%

advice safety on par with GPs

CE-marked Class IIa

regulated medical device

1M+

clinician hours invested in medical knowledge

Start reaching patients earlier